Rhabdomyolysis
Information
- Disease name
- Rhabdomyolysis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT06101680 | Active, not recruiting | RhabdomYolyse in Intensive caRe | October 1, 2023 | January 1, 2024 | |
NCT00391911 | Completed | Phase 2 | Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis | November 2006 | December 2010 |
NCT00592657 | Completed | Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions | January 2008 | April 2008 | |
NCT00241748 | Completed | Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event | September 2005 | December 2011 | |
NCT01467180 | Completed | N/A | Myoglobin Removal by High Cut-off CVVHD | November 2011 | May 2014 |
NCT01544231 | Completed | Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis | August 2013 | December 2015 | |
NCT01976936 | Completed | Phase 2 | Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2 | February 2009 | January 2017 |
NCT02671604 | Completed | Rhabdomyolysis and Robot-assisted Radical Prostatectomy | January 2014 | January 2015 | |
NCT03737513 | Completed | Exercise-induced Collective Rhabdomyolysis | September 9, 2018 | May 31, 2019 | |
NCT03986736 | Completed | Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma | June 15, 2019 | December 31, 2022 | |
NCT04118608 | Completed | Rhabdomyolysis - a Study of Patient Characteristics and Laboratory Values to Guide Treatment | August 4, 2019 | December 22, 2023 | |
NCT04913298 | Completed | N/A | Prospective Study for the Application of Cytosorb® in Critically Ill Patients | March 1, 2021 | December 15, 2023 |
NCT06338423 | Completed | N/A | Use of a Vacuum Mattress During Laparoscopic Sleeve Gastrectomy to Reduce the Concentration of Rhabdomyolysis Markers and Acute Renal Failure | January 1, 2015 | December 31, 2022 |
NCT06429982 | Not yet recruiting | Phase 1 | Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols | October 1, 2024 | December 31, 2026 |
NCT05146336 | Recruiting | CytOSorb TreatMent Of Critically Ill PatientS Registry | June 22, 2022 | September 2032 | |
NCT04610619 | Unknown status | Multisystem Features of Malignant Hyperthermia or Rhabdomyolysis Related to RYR1 Variants | August 19, 2020 | January 2022 | |
NCT02498366 | Unknown status | N/A | Exertional Rhabdomyolysis- Characterization of Prediction Tests for Return to Duty | October 2015 | December 2016 |
NCT02518724 | Unknown status | N/A | The Effect of Remote Ischemic Preconditioning on Physical Performance and Exertional Rhabdomyolysis | January 2016 | December 2016 |
NCT00549029 | Unknown status | The Association of Genetic Polymorphisms With Statin-Induced Myopathy. | August 2007 | January 2008 | |
NCT01022450 | Unknown status | Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients | November 2009 | ||
NCT02896517 | Withdrawn | Support for the Rhabdomyolysis in an Emergency Department | October 1, 2016 | October 1, 2016 | |
NCT02111018 | Withdrawn | Phase 2 | Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis | March 2014 |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0003201
- MeSH unique ID (MeSH (Medical Subject Headings))
- D012206